BioHarvest Sciences Inc. (BHSC.CN)
CAD 8.9
(1.71%)
CAD 8.9
(1.71%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.42 Million USD | -14.67% |
| 2022 | 1.67 Million USD | -26.53% |
| 2021 | 2.27 Million USD | -5.13% |
| 2020 | 2.39 Million USD | 648.75% |
| 2019 | 320 Thousand USD | 305.06% |
| 2018 | 79 Thousand CAD | -99.51% |
| 2017 | 16.23 Million CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | -100.0% |
| 2014 | 16.63 Thousand CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 726 Thousand USD | 0.0% |
| 2024 Q2 | 9.22 Million USD | 0.0% |
| 2023 Q1 | 1.54 Million USD | -7.31% |
| 2023 Q2 | 1.58 Million USD | 2.58% |
| 2023 FY | 1.42 Million USD | -14.67% |
| 2023 Q4 | 1.42 Million USD | -1.32% |
| 2023 Q3 | 1.44 Million USD | -9.07% |
| 2022 Q1 | 2.13 Million USD | -6.16% |
| 2022 Q4 | 1.67 Million USD | -4.08% |
| 2022 Q3 | 1.74 Million USD | -5.99% |
| 2022 Q2 | 1.85 Million USD | -13.17% |
| 2022 FY | 1.67 Million USD | -26.53% |
| 2021 Q1 | 2.31 Million USD | -3.42% |
| 2021 FY | 2.27 Million USD | -5.13% |
| 2021 Q4 | 2.27 Million USD | -0.26% |
| 2021 Q3 | 2.27 Million USD | -0.26% |
| 2021 Q2 | 2.28 Million USD | -1.25% |
| 2020 FY | 2.39 Million USD | 648.75% |
| 2020 Q2 | 202 Thousand USD | -20.47% |
| 2020 Q4 | 2.39 Million USD | 811.03% |
| 2020 Q3 | 263 Thousand USD | 30.2% |
| 2020 Q1 | 254 Thousand USD | -22.32% |
| 2019 FY | 320 Thousand USD | 305.06% |
| 2019 Q3 | 490 Thousand USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q1 | - CAD | -100.0% |
| 2019 Q4 | 327 Thousand USD | -33.27% |
| 2018 Q4 | 79 Thousand CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 FY | 79 Thousand CAD | -99.51% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 FY | 16.23 Million CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q2 | - CAD | -100.0% |
| 2015 Q1 | 16.63 Thousand CAD | 0.0% |
| 2015 FY | - CAD | -100.0% |
| 2014 FY | 16.63 Thousand CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aion Therapeutic Inc. | - CAD | -Infinity% |
| Ayurcann Holdings Corp. | 129.01 Thousand CAD | -1004.488% |
| Blueberries Medical Corp. | 11.04 Thousand CAD | -12805.271% |
| The BC Bud Corporation | - CAD | -Infinity% |
| BioNxt Solutions Inc. | - CAD | -Infinity% |
| CordovaCann Corp. | 3.31 Million CAD | 57.032% |
| Christina Lake Cannabis Corp. | 4.48 Million CAD | 68.25% |
| Captor Capital Corp. | 5.47 Million CAD | 73.986% |
| City View Green Holdings Inc. | - CAD | -Infinity% |
| 1CM Inc. | 4.14 Million CAD | 65.639% |
| Global Hemp Group Inc. | 3.55 Million CAD | 59.934% |
| Greenway Greenhouse Cannabis Corporation | 7.37 Million CAD | 80.67% |
| IM Cannabis Corp. | 394 Thousand CAD | -261.675% |
| Lobe Sciences Ltd. | - CAD | -Infinity% |
| Maple Leaf Green World Inc. | - CAD | -Infinity% |
| Mountain Valley MD Holdings Inc. | - CAD | -Infinity% |
| Nextleaf Solutions Ltd. | 384.69 Thousand CAD | -270.425% |
| Ovation Science Inc. | 18.26 Thousand CAD | -7700.953% |
| Pharmadrug Inc. | - CAD | -Infinity% |
| Captiva Verde Wellness Corp. | - CAD | -Infinity% |
| RAMM Pharma Corp. | 179.76 Thousand CAD | -692.724% |
| RIV Capital Inc. | 144.15 Million CAD | 99.011% |
| Revive Therapeutics Ltd. | - CAD | -Infinity% |
| Red White & Bloom Brands Inc. | 21.42 Million CAD | 93.348% |
| SLANG Worldwide Inc. | 3.16 Million CAD | 55.01% |
| 1933 Industries Inc. | 12.57 Million CAD | 88.668% |
| Red Light Holland Corp. | 291.08 Thousand CAD | -389.549% |
| Top Strike Resources Corp. | 1.7 Million CAD | 16.243% |
| Xebra Brands Ltd. | - CAD | -Infinity% |
| Adastra Holdings Ltd. | 147.51 Thousand CAD | -866.017% |